Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Mayo Clinic
Deal Size : Undisclosed
Deal Type : Collaboration
Precisio Biotix Therapeutics Announces Collaboration with Mayo Clinic
Details : The collaboration will include co-development of novel precision antibacterials, including first-in-class novel lysins, targeting indications prone to antimicrobial-resistant infections.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 14, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Mayo Clinic
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Bacteriophage Microcapsule
Therapeutic Area : Dermatology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
Details : Undisclosed
Product Name : Bactelide
Product Type : Microorganism
Upfront Cash : Inapplicable
March 25, 2021
Lead Product(s) : Bacteriophage Microcapsule
Therapeutic Area : Dermatology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bacteriophage Cocktail
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
March 26, 2020
Lead Product(s) : Bacteriophage Cocktail
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable